SCHEMBL8891386

SCHEMBL8891386

S=Cc1nccn1-n1ccnc1

nearest known ligand 0.31

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
CYP19A1 P11511 2/20 0.31
CYP17A1 P05093 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL544751 0.81 ALDH1A1 (0.31)
SCHEMBL27895939 0.71 CYP2E1 (0.35) CYP19A1
SCHEMBL27469745 0.67 ALPG (0.33) CYP19A1
SCHEMBL27903564 0.64
SCHEMBL27982363 0.64 MEN1 (0.42) CYP17A1
SCHEMBL1412677 0.64 NFKB1 (0.47) CYP19A1
SCHEMBL27961586 0.62 NFKB1 (0.45) CYP19A1
Ammonia Solution, Strong SCHEMBL27340998 0.62 NFKB1 (0.45) CYP19A1
SCHEMBL28900913 0.58 TRIM24 (0.41)
SCHEMBL9464877 0.56 CYP3A4 (0.41) CYP19A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 22 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5594034-A ADMINISTERING DIRECT ACTING 5-HYDROXYTRYPTAMINE AGONIST TO MAMMAL ELI LILLY AND COMPANY (US) 1997-01-14 US disclosed
US-5594025-A Method of inhibiting gastric acid secretion with 5-substituted-3-aminochromane ELI LILLY AND COMPANY (US) 1997-01-14 US disclosed
EP-0455510-B1 Use of 5-HT1A receptor agonist compounds for inhibiting gastric acid secretion LILLY CO ELI (US) 1996-11-27 EP disclosed
US-5576352-A Method of inhibiting gastric acid secretion with aryloxypropanolamines ELI LILLY AND COMPANY (US) 1996-11-19 US disclosed
EP-0444854-B1 6-Substituted hexahydrobenz[cd]indoles LILLY CO ELI (US) 1996-09-25 EP disclosed
US-5470853-A Useful in modifying the serotonin function in the body ELI LILLY AND COMPANY (US) 1995-11-28 US disclosed
US-5462962-A Administering to mammals to selectively block biological receptors to treat anxiety or depression ELI LILLY AND COMPANY (US) 1995-10-31 US disclosed
US-5457120-A Antisecretory and antiserotonine agents ELI LILLY AND COMPANY (US) 1995-10-10 US disclosed
EP-0392768-B1 Tetrahydrobenz[C,D] indole serotonin agonists LILLY CO ELI (US) 1994-12-07 EP disclosed
US-5340838-A Administering serotonin agonist to mammals ELI LILLY AND COMPANY (US) 1994-08-23 US disclosed
US-5204340-A Anxiolytic agents; antidepressants; consumptive disorders,e.g. obesity, alcoholism and smoking; sexual dysfunction ELI LILLY AND COMPANY (US) 1993-04-20 US disclosed
US-5158956-A Administering serotonin receptor agonist ELI LILLY AND COMPANY (US) 1992-10-27 US disclosed
EP-0202024-B1 ADDITIVE FOR LUBRICATING OILS AND HYDROCARBON FUELS CHEVRON RESEARCH AND TECHNOLOGY COMPANY (US) 1992-06-17 EP disclosed
US-5096908-A 5-HT1A agonist ELI LILLY AND COMPANY (US) 1992-03-17 US disclosed
EP-0455510-A2 Use of 5-HT1A receptor agonist compounds for inhibiting gastric acid secretion ELI LILLY AND COMPANY (US) 1991-11-06 EP disclosed
EP-0444854-A2 6-Substituted hexahydrobenz[cd]indoles ELI LILLY AND COMPANY (US) 1991-09-04 EP disclosed
US-4747963-A Lubricating oil compositions containing modified succinimides (VII) CHEVRON RESEARCH COMPANY (US) 1988-05-31 US disclosed
US-4666459-A Modified succinimides (VII) CHEVRON RESEARCH COMPANY (US) 1987-05-19 US disclosed
US-4663062-A Lubricating oil compositions containing modified succinimides (VII) CHEVRON RESEARCH COMPANY (US) 1987-05-05 US disclosed
EP-0202024-A2 Additive for lubricating oils and hydrocarbon fuels CHEVRON RESEARCH AND TECHNOLOGY COMPANY (US) 1986-11-20 EP disclosed